Biocryst Pharmaceuticals Inc (BCRX)
Cost of Revenue
$3.84M
Quarterly · Period ending: · USD
BCRX Cost of Revenue
Latest reported$3.84Mperiod ending
Latest reported$3.84Mperiod ending
BCRX Quarterly Cost of Revenue ($900.00K → $3.84M)
Quarterly cost of revenue
High-resolution chart · PNG
BCRX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 3,840,000 | |
| 703,138,000 | |
| 9,916,000 | |
| 2,522,000 | |
| 2,798,000 | |
| 4,568,000 | |
| 6,131,000 | |
| 3,228,000 | |
| 1,699,000 | |
| 1,265,000 | |
| 1,637,000 | |
| 1,136,000 | |
| 950,000 | |
| 938,000 | |
| 2,496,000 | |
| 3,613,000 | |
| 247,000 | |
| 238,000 | |
| 419,000 | |
| 615,000 | |
| 343,000 | |
| 5,923,000 | |
| 81,000 | |
| 1,526,000 | |
| 0 | |
| 69,000 | |
| 2,571,000 | |
| 18,000 | |
| 26,000 | |
| 1,486,000 | |
| 70,000 | |
| 18,000 | |
| 243,000 | |
| 140,000 | |
| 129,000 | |
| 1,257,000 | |
| 22,000 | |
| 294,000 | |
| 2,452,000 | |
| 143,000 | |
| 27,000 | |
| 77,000 | |
| 28,000 | |
| 1,351,000 | |
| 442,000 | |
| 75,000 | |
| 44,000 | |
| 13,036,000 | |
| 5,000 | |
| 73,000 | |
| 17,000 | |
| 7,735,000 | |
| 4,000 | |
| 77,000 | |
| 18,000 | |
| 12,186,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 459 | |
| 0 | |
| 0 | |
| 86,000 | |
| 4,543,914 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |